Skip to content

Preliminary exploratory study on the antithrombotic effect of tirofiban in stent assisted embolization of ruptured aneurysms.

Preliminary exploratory study on the antithrombotic effect of tirofiban in stent assisted embolization of ruptured aneurysms.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067188
Enrollment
Unknown
Registered
2022-12-29
Start date
2022-12-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ruptured intracranial aneurysm

Interventions

Control group:Oral loading dose double antibody before interventional embolization of ruptured intracranial aneurysm.
Experimental group1:Interventional embolization of ruptured intracranial aneurysms perioperative use of tirofiban.
Experimental group2:Intravenous application of tirofiban in perioperative period.

Sponsors

The First Affiliated Hospital of Army Medical University,PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The subarachnoid hemorrhage was diagnosed by CT, (2) DSA angiography or CTA examination showed that there was rupture of intracranial aneurysm, (3) The patient or his family members agreed to perform stent assisted interventional embolization of intracranial aneurysms, (4) The patient or his family members agree to use antiplatelet drugs, (5) When signing the informed consent form, there is no limit to men and women aged 18-80,

Exclusion criteria

Exclusion criteria: (1) The patient is allergic to any component of tirofiban, (2) Recent (within 1 year) bleeding, including gastrointestinal bleeding or clinically significant urogenital bleeding, (3) Known history of coagulopathy, platelet abnormalities, or thrombocytopenia, (4) Platelet count is less than 150000mm/3, (5) History of cerebrovascular disease within 1 year, (6) Recent epidural surgery, (7) Severe uncontrolled hypertension (systolic blood pressure greater than 180mmHg and/or diastolic blood pressure greater than 110mmHg), (8) Hemorrhagic retinopathy, (9) Chronic hemodialysis, (10) History of major surgery or severe physical trauma within 1 month, (11) Patients with lobar hematoma due to aneurysm rupture and midline displacement greater than 1cm who need decompressive craniectomy, (12) On admission, CT showed clear hydrocephalus, and patients needed to open the external drainage of the operating ventricle,

Design outcomes

Primary

MeasureTime frame
Effectiveness;

Secondary

MeasureTime frame
Safety;

Countries

China

Contacts

Public ContactHongping Miu

The First Affiliated Hospital of Army Medical University,PLA

wksalm@163.com13320293522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026